Patent classifications
A23L2/00
Enhanced caffeinated beverage composition
An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.
Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
This disclosure provides compositions and methods for treating or preventing liver diseases and disorders with hyperammonemia or muscle wasting in a subject.
Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
This disclosure provides compositions and methods for treating or preventing liver diseases and disorders with hyperammonemia or muscle wasting in a subject.
ACTIVE INGREDIENT-CONTAINING NANOEMULSIONS
The present disclosure provides nanoemulsions including one or more active ingredients (e.g., one or more cannabinoid and/or cannabimimetics), formulated for use as tinctures or shots. Such nanoemulsions, tinctures, and shots can exhibit high physical stability, e.g., exhibiting no observable phase separation over a period of 6 months or more or 12 months or more.
Edible composition for reducing the digestion or absorption of the harmful/toxic substance
The invention relates to compositions and methods for adjusting digestive or absorptive rates and ratio of foods or drinks or reducing a digestive solution. Particularly, the invention provides a composition comprising an insoluble dietary fiber and a prebiotic gel and its application in reducing digestive or absorptive rates and ratio of foods or drinks.
Edible composition for reducing the digestion or absorption of the harmful/toxic substance
The invention relates to compositions and methods for adjusting digestive or absorptive rates and ratio of foods or drinks or reducing a digestive solution. Particularly, the invention provides a composition comprising an insoluble dietary fiber and a prebiotic gel and its application in reducing digestive or absorptive rates and ratio of foods or drinks.
CONTINUOUS MULTI-STREAM LIQUID PRODUCT DEAERATION SYSTEM AND METHOD
A system for deaeration of constituents of a liquid product blend includes a first liquid stream supply system and a second liquid stream supply system. A control system is configured to: (i) monitor flow of the first liquid and responsively/automatically control flow of the first deaeration gas in order to achieve a first target ratio of first deaeration gas to first liquid; and/or (ii) monitor flow of the second liquid and responsively/automatically control flow of the second deaeration gas in order to achieve a second target ratio of second deaeration gas to second liquid; and/or (iii) monitor a dissolved oxygen level of (a) the first liquid, at a location downstream of injection of the first deaeration gas, and (b) a combined liquid formed by mixing the first liquid and the second liquid, and to adjust the system based upon the dissolved oxygen level of the combined liquid.
EDIBLE SILK AND METHODS OF MAKING AND USING THEREOF
This disclosure provides novel silk fibroin protein based additives for foods or beverage products, and foodstuffs mixed or coated with pure silk fibroin-based proteins or protein fragments, and methods of making thereof.
ACETIC ACID-CONTAINING BEVERAGE
[Problem] To provide a novel technique with which it is possible to reduce acetic acid irritation and difficulty to drink derived from acetic acid which may be sensed during drinking of an acetic acid-containing beverage.
[Solution] This beverage contains acetic acid in an amount of 10-800 ppm and gluconic acid in an amount of 50-2000 ppm, and has an acidity due to citric acid of 0.1-0.4 g/100 ml.
[Selected Drawing] None
REDUCED NICOTINAMIDERIBOSIDES FOR THE TREATMENT/PREVENTION OF LIVER DISEASE
The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of prevention and/or treatment of liver disease and/or conditions. In one embodiment of the invention, said compounds and compositions of the invention improve liver by maintaining or improving liver function; maintaining or improving hepatocyte function; and improving liver recovery and regeneration after injury, transplantation or surgery. In another embodiment of the invention, compounds and compositions of the invention may be used in methods to prevent and/or treat liver diseases and/or conditions such as: non-alcoholic fatty liver disease (NAFLD), alcoholic fatty liver disease, hepatic steatosis, cirrhosis and/or recovery and regeneration after liver injury, transplantation or surgery.